In fact, over-expression of anti-apoptosis proteins Bcl-2 and Mcl-1 served as the hallmarks of leukaemia and myeloma; for this reason, the discovery of new drugs that can inhibit the expression of Bcl-2 and Mcl-1 is important in curing leukemia. Here, BCL2 is linked to plasma cell myeloma.